News
While mRNA changed the game in vaccines, leveraging the technology to develop treatments has been trickier to navigate.
NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...
Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...
StockStory.org on MSN
Why Moderna (MRNA) Stock Is Trading Up Today
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced positive preliminary data for its updated 2025-2026 COVID-19 vaccine, ...
Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he's pulling the plug on nearly $500 million in funding for the development of mRNA vaccines. Here's how they work.
5don MSN
Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots
The report says officials plan to include the claim in a presentation next week to a key vaccine panel that advises the CDC ...
WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the mRNA COVID vaccine?
StockStory.org on MSN
Why Moderna (MRNA) Shares Are Falling Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 4.8% in the afternoon session after competitors Pfizer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results